SCHEMBL659026

SCHEMBL659026

Nc1nccc2cc(-c3ccccc3)oc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.58
NPC1 O15118 1/20 0.58
MAOA P21397 2/20 0.50
MAOB P27338 2/20 0.50
TLR8 Q9NR97 2/20 0.49
F12 P00748 1/20 0.42
PLAU P00749 1/20 0.42
NCF1 P14598 1/20 0.42
NOS3 P29474 1/20 0.42
NOS1 P29475 1/20 0.42
NOS2 P35228 1/20 0.42
BACE1 P56817 1/20 0.42
CYP1A1 P04798 3/20 0.40
CYP1A2 P05177 3/20 0.40
CYP1B1 Q16678 3/20 0.40
PTGES O14684 1/20 0.40
ASIC3 Q9UHC3 1/20 0.40
AURKA O14965 1/20 0.40
HSP90AA1 P07900 1/20 0.40
PRKACA P17612 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL659990 0.77 TLR8 (0.43) RAB9ANPC1TLR8NOS3NOS2
SCHEMBL658805 0.75 MAP3K7 (0.48) RAB9ANPC1TLR8MAP3K7TAB1
SCHEMBL8154245 0.74 NPC1 (1.00) RAB9ANPC1MAOAMAOBCYP1A1
SCHEMBL25143574 0.72 MAOA (0.42) RAB9ANPC1MAOAMAOBCYP1A1
SCHEMBL8267507 0.72 TLR8 (0.58) RAB9AMAOATLR8F12PLAU
SCHEMBL658395 0.72 TLR8 (0.54) RAB9ATLR8F12PLAUNCF1
SCHEMBL659953 0.71 TLR8 (0.41) RAB9ANPC1MAOAMAOBTLR8
SCHEMBL659270 0.70 MAP3K7 (0.47) RAB9ANPC1MAOAMAOBTLR8
SCHEMBL660235 0.70 LMNA (0.44) RAB9ATLR8CYP1A2KDM4EALDH1A1
SCHEMBL15231528 0.70 TLR8 (0.49) TLR8TP53TBXAS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8378104-B2 7-aminofuropyridine derivatives OSI Pharmaceuticals, LLC (US) 2013-02-19 US disclosed
EP-2534156-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI Pharmaceuticals, LLC (US) 2012-12-19 EP disclosed
US-20120046267-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI PHARMACEUTICALS, INC. 2012-02-23 US disclosed
WO-2011100502-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI Pharmaceuticals, LLC (US) 2011-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046267-A1 7-AMINOFUROPYRIDINE DERIVATIVES MAP3K5, STK17A, MAPKAPK5 RAB9A 1727/4885NPC1 976/4885MAOA 4144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.